David W. Bahler

3.5k total citations
64 papers, 2.6k citations indexed

About

David W. Bahler is a scholar working on Pathology and Forensic Medicine, Immunology and Genetics. According to data from OpenAlex, David W. Bahler has authored 64 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 27 papers in Immunology and 26 papers in Genetics. Recurrent topics in David W. Bahler's work include Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Cutaneous lymphoproliferative disorders research (13 papers). David W. Bahler is often cited by papers focused on Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (25 papers) and Cutaneous lymphoproliferative disorders research (13 papers). David W. Bahler collaborates with scholars based in United States, Netherlands and Italy. David W. Bahler's co-authors include Steven H. Swerdlow, Ronald Levy, Sherrie L. Perkins, L Hartung, Joseph Locker, Michael A. Nalesnik, Beverly P. Nelson, John J. Fung, Sally Hill and Kojo S.J. Elenitoba‐Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and The Journal of Experimental Medicine.

In The Last Decade

David W. Bahler

64 papers receiving 2.5k citations

Peers

Countries citing papers authored by David W. Bahler

Since Specialization

Citations

This map shows the geographic impact of David W. Bahler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Bahler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Bahler more than expected).

Fields of papers citing papers by David W. Bahler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Bahler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Bahler. The network helps show where David W. Bahler may publish in the future.

Co-authorship network of co-authors of David W. Bahler

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Bahler. A scholar is included among the top collaborators of David W. Bahler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Bahler. David W. Bahler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK–STAT pathway in Sézary syndrome 2015 ·Nature Communications ·Mark J. Kiel, Anagh A. Sahasrabuddhe, Delphine Rolland, Thirunavukkarasu Velusamy, Fu‐Zon Chung, Matthew Schaller, Nathanael G. Bailey, Bryan L. Betz, Roberto N. Miranda, Pierluigi Porcu, John C. Byrd, L. Jeffrey Medeiros, Steven L. Kunkel, David W. Bahler, Megan S. Lim, Kojo S.J. Elenitoba‐Johnson	143
2	Next-generation IgVH sequencing CLL-like monoclonal B-cell lymphocytosis reveals frequent oligoclonality and ongoing hypermutation 2015 ·Leukemia ·Mark Klinger, Jianbiao Zheng, Kojo S.J. Elenitoba‐Johnson, S L Perkins, Malek Faham, David W. Bahler	15
3	Diffuse Large B-cell Lymphoma With Aberrant Expression of the T-cell Antigens CD2 and CD7 2011 ·Applied immunohistochemistry & molecular morphology ·Nikhil Sangle, Archana M. Agarwal, Kristi J. Smock, (unknown), Roger A. Warnke, David W. Bahler, Sherrie L. Perkins	14
4	A pyrosequencing-based test for detection and relative quantification of the BCR-ABL1 T315I point mutation 2011 ·Journal of Clinical Pathology ·Jonathan A. Schumacher, Philippe Szankasi, David W. Bahler, Albert K. Ho, Todd W. Kelley	5
5	Clinical Laboratory Analysis of Immunoglobulin Heavy Chain Variable Region Genes for Chronic Lymphocytic Leukemia Prognosis 2010 ·Journal of Molecular Diagnostics ·Philippe Szankasi, David W. Bahler	5
6	Combined testing for CCAAT/enhancer-binding protein alpha (CEBPA) mutations and promoter methylation in acute myeloid leukemia demonstrates shared phenotypic features 2010 ·Leukemia Research ·Philippe Szankasi, Albert K. Ho, David W. Bahler, Olga Efimova, Todd W. Kelley	12
7	Immunomagnetic bead separation of mononuclear cells from contaminating granulocytes in cryopreserved blood samples 2009 ·Cryobiology ·Sergey N. Preobrazhensky, David W. Bahler	7
8	Use of similar immunoglobulin VH gene segments by MALT lymphomas of the ocular adnexa 2009 ·Modern Pathology ·David W. Bahler, Philippe Szankasi, Sucheta Kulkarni, Raymond R. Tubbs, James R. Cook, Steven H. Swerdlow	22
9	A New DNA-Based Test for Detection of Nucleophosmin Exon 12 Mutations by Capillary Electrophoresis 2008 ·Journal of Molecular Diagnostics ·Philippe Szankasi, Mohamed Jama, David W. Bahler	28
10	Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma 2008 ·Leukemia & lymphoma ·(unknown), Eric C. Vonderheid, Christopher J. Thoburn, Mariusz A. Wasik, David W. Bahler, Allan D. Hess	38
11	Laboratory Practice Guidelines for Detecting and Reporting BCR-ABL Drug Resistance Mutations in Chronic Myelogenous Leukemia and Acute Lymphoblastic Leukemia 2008 ·Journal of Molecular Diagnostics ·Dan Jones, Suzanne Kamel‐Reid, David W. Bahler, Henry Y. Dong, Kojo S.J. Elenitoba‐Johnson, Richard D. Press, Neil B. Quigley, Paul G. Rothberg, (unknown), David S. Viswanatha, Karen E. Weck, James L. Zehnder	45
12	Optimization of flow cytometric measurement of ZAP‐70 in chronic lymphocytic leukemia 2007 ·Cytometry Part B Clinical Cytometry ·Sergey N. Preobrazhensky, David W. Bahler	12
13	Analysis of immunoglobulin V_H genes suggests cutaneous marginal zone B‐cell lymphomas recognise similar antigens 2005 ·British Journal of Haematology ·David W. Bahler, (unknown), (unknown), Steven H. Swerdlow	11
14	Importance of CD117 in the evaluation of acute leukemias by flow cytometry 2003 ·Cytometry Part B Clinical Cytometry ·James Newell, Melissa H. Cessna, (unknown), L Hartung, David W. Bahler	25
15	Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes 2003 ·Human Pathology ·Laurentia Nodit, David W. Bahler, Samuel A. Jacobs, Joseph Locker, Steven H. Swerdlow	72
16	Histological and Immunoglobulin VH Gene Analysis of Interfollicular Small Lymphocytic Lymphoma Provides Evidence for Two Types 2000 ·American Journal Of Pathology ·David W. Bahler, Nadine S. Aguilera, (unknown), Susan L. Abbondanzo, Steven H. Swerdlow	20
17	Epstein–Barr Virus-Negative Post-Transplant Lymphoproliferative Disorders 2000 ·The American Journal of Surgical Pathology ·Beverly P. Nelson, Michael A. Nalesnik, David W. Bahler, Joseph Locker, John J. Fung, Steven H. Swerdlow	223
18	Salivary gland lymphoid infiltrates associated with lymphoepithelial lesions: A clinicopathologic, immunophenotypic, and genotypic study 1997 ·Human Pathology ·(unknown), Silloo B. Kapadia, David W. Bahler, Jonas T. Johnson, Steven H. Swerdlow	74
19	Lysis of a lung carcinoma by poly I:C-induced natural killer cells is independent of the expression of class I histocompatibility antigens. 1988 ·The Journal of Immunology ·Gunther Dennert, Carol S. Landon, Elizabeth M. Lord, David W. Bahler, (unknown)	47
20	Molecular analysis of deficient class I H-2 antigen expression by mouse lung carcinoma cells. 1988 ·The Journal of Immunology ·David W. Bahler, Karen Cerosaletti, Edith M. Lord, John G. Frelinger	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact